{"id":3753,"date":"2014-01-30T13:11:15","date_gmt":"2014-01-30T13:11:15","guid":{"rendered":"\/?p=3753"},"modified":"2014-01-30T13:11:17","modified_gmt":"2014-01-30T13:11:17","slug":"easton-pharmaceuticals-inc-otcmktseaph-tries-to-hold-positions-with-new-pr","status":"publish","type":"post","link":"\/articles\/easton-pharmaceuticals-inc-otcmktseaph-tries-to-hold-positions-with-new-pr\/","title":{"rendered":"Easton Pharmaceuticals, Inc. (OTCMKTS:EAPH) Tries to Hold Positions with New PR"},"content":{"rendered":"

Easton Pharmaceuticals, Inc. (OTCMKTS:EAPH<\/a>) is on track, despite the setback, to end the week with a double price. On Wednesday, EAPH<\/a> added more than 22%om nixed sentiment, reaching a price of $0.023, on buying volumes of $1.18 million. Now the question is whether EAPH<\/a> has enough strength and enticement to continue the climb, or it would stall as it did earlier this month. \"EAPH3001.png\" <\/p>\n

EAPH<\/a> saved the day only after a new press release, proving again that it has been rising largely thanks to concerted promotional efforts by email or PR. Still, there is no new message from professional pumpers- and EAPH<\/a> has had to issue another promise on its bright future of cannabis sales.<\/p>\n

The only problem is that the new PR is just as vague as the older pieces, pointing to negotiations that just might lead to a partnership with as yet unnamed Canadian company. Also, EAPH<\/a> is looking for a Canada-based legal expert on medical marijuana, so while the intentions may be solid-looking, there is nothing committed in the whole message.<\/p>\n

Still, investors’ forums seem to like the news, as they stir a commotion just enough to lift up the relatively underpriced shares. A price of five cents is seen as realistic.<\/p>\n

But compared to other pot stocks, EAPH<\/a> remains parochial- in that it has not seen the mainstream attention that lifted GreenGro Technologies, Inc. (OTCMKTS:GRNH<\/a>) on unseen volumes, as well as Terra Tech Corp. (OTCBB:TRTC<\/a>).<\/p>\n

Even at the improved price, EAPH<\/a> has a relatively small market cap of about $5 million, which shows comparatively less disproportion to the financial filings:<\/p>\n